Apixaban package insert pdf

Apixaban package insert pdf

Rating: 4.4 / 5 (2823 votes)

Downloads: 13300

CLICK HERE TO DOWNLOAD

.

.

.

.

.

.

.

.

.

.

(B) SPINAL/EPIDURAL ELIQUIS is a blood thinner medicine that is used to lower the risk of stroke and blood clots in patients with AFib not caused by a heart valve problem. Even though you cannot feel Missing: pdf ELIQUIS (apixaban) is indicated for: the prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery PRESENTATION: Film-coated tablets;mg and mg TION: Prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation ELIQUIS (apixaban) tablets, for oral use Initial U.S. ApprovalWARNING: (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS. This means that Eliquis has been proven to be safe and effective, but serious harm, such as severe bleeding or ELIQUIS is a blood thinner medicine that is used to lower the risk of stroke and blood clots in patients with AFib not caused by a heart valve problem. Dose reduction The recommended dose of apixaban is mg taken orally twice daily in patients with NVAF and at least two of the following characteristics: age ≥years, body weight ≤kg, or serum creatinine ≥ mg/dL (micromole/L). Therapy should be continued long Apixaban (Eliquis) is indicated to reduce the risk of stroke, systemic embolism, and death in patients with nonvalvular atrial fibrillation with one or more risk factors, including patients unsuitable for warfarin Reduce dose by%: For patients receiving ELIQUIS® (apixaban) doses ofmg ormg twice daily, when ELIQUIS is coadministered with drugs that are combined P-gp and strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, or ritonavir) ELIQUIS. Prevention of venous thromboembolic events (VTE) in adult ELIQUIS. APPROVED PACKAGE INSERT. Prevention of VTE in Surgical Patients: Elective hip or knee replacement surgery. Eliquis is a high-alert medicine. What is the most important information I should know about ELIQUIS? For people taking ELIQUIS for atrial fibrillation: People with atrial fibrillation (a type of irregular heartbeat) are at an increased risk of forming a blood clot in the heart, which can travel to the brain, causing a stroke, or to other parts of the body The recommended dose of apixaban ismg taken orally twice daily. ELIQUIS (apixaban) tablets, for oral use Initial U.S. ApprovalWARNING: (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF Eliquis (apixaban) Take extra care! Dose reduction The recommended dose of apixaban is mg taken orally twice daily in patients with NVAF Missing: pdf Therapeutic Indications. (B) SPINAL/EPIDURAL HEMATOMA (apixaban) is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillationDOSAGE AND ADMINISTRATIONRecommended Dose. ELIQUIS (apixaban) tablets, for oral use Initial U.S. ApprovalWARNING: (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS. The recommended APPROVED PACKAGE INSERT. Even though you cannot feel that ELIQUIS is working, it is important to continue to take ELIQUIS as your healthcare professional prescribes PRESENTATION: Film-coated tablets;mg and mg TION: Prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (NVAF) with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA), age ≥years, hypertension, diabet SCHEDULING STATUS: SPROPRIETARY NAME AND DOSAGE FORM: ELIQUIS® 2,5 mg (Film-coated Tablets) ELIQUIS®mg (Film-coated Tablets) COMPOSITION: Each film-coated tablet contains either 2,5 mg ormg apixaban with the following inactive ingredients: e cellulose and (apixaban) tablets. SCHEDULING STATUS: SPROPRIETARY NAME AND DOSAGE FORM: ELIQUIS® 2,5 mg (Film-coated Tablets) ELIQUIS®mg (Film (apixaban) is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillationDOSAGE AND ADMINISTRATIONRecommended Tags Reduce dose by%: For patients receiving ELIQUIS® (apixaban) doses ofmg ormg twice daily, when ELIQUIS is coadministered with drugs that are combined P-gp and The recommended dose of apixaban ismg taken orally twice daily.